|
Bayer launches unit to develop new precision health consumer products
|
31 May 2023 |
|
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
|
16 May 2023 |
|
Bayer opens first Co.Lab Life science incubator in Cambridge
|
10 May 2023 |
|
Bayer Pharmaceuticals accelerates innovations for patients
|
31 March 2023 |
|
BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
|
21 March 2023 |
|
Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes
|
13 February 2023 |
|
2022 Otto Bayer Award goes to Professor Frank Glorius
|
07 February 2023 |
|
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
|
30 January 2023 |
|
Bayer to accelerate drug discovery with Google Cloud's high-performance compute power
|
12 January 2023 |
|
NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs
|
10 January 2023 |
|
Recombinant adeno-associated virus (rAAV) technology pioneered by AskBio's Dr. Jude Samulski is key component of all FDA approved AAV gene therapeutics
|
20 December 2022 |
|
Bayer launches industry-first public database listing company's science collaborations and partnerships in the U.S.
|
09 December 2022 |
|
Bayer supports rebuilding of Ukrainian healthcare system by donating 1.3 million euros
|
02 December 2022 |
|
Vividion Therapeutics names Jenna Goldberg as Chief Medical Officer
|
09 November 2022 |
|
Bayer with continued strong performance
|
08 November 2022 |
|
Bayer signs grant agreement to advance innovation in non-hormonal contraception
|
20 October 2022 |
|
Bayer supports demining in Ukraine with donation to non-profit "Fondation suisse de déminage"
|
18 August 2022 |
|
Bayer Consumer Health leaders propose new principles for science-led self-care
|
02 August 2022 |
|
Bayer to sell men's health product Nebido™ to Grünenthal
|
18 July 2022 |
|
Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
|
29 June 2022 |